CD Private Equity Fund I
CD Private Equity Fund I Fundamental Analysis
CD Private Equity Fund I (CD1.AX) shows weak financial fundamentals with a PE ratio of 19.55, profit margin of 12.15%, and ROE of 2.05%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 51.4/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze CD1.AX's fundamental strength across five key dimensions:
Efficiency Score
WeakCD1.AX struggles to generate sufficient returns from assets.
Valuation Score
ExcellentCD1.AX trades at attractive valuation levels.
Growth Score
ModerateCD1.AX shows steady but slowing expansion.
Financial Health Score
ExcellentCD1.AX maintains a strong and stable balance sheet.
Profitability Score
WeakCD1.AX struggles to sustain strong margins.
Key Financial Metrics
Is CD1.AX Expensive or Cheap?
P/E Ratio
CD1.AX trades at 19.55 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, CD1.AX's PEG of 0.20 indicates potential undervaluation.
Price to Book
The market values CD Private Equity Fund I at 0.43 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 32.50 times EBITDA. This signals the market has high growth expectations.
How Well Does CD1.AX Make Money?
Net Profit Margin
For every $100 in sales, CD Private Equity Fund I keeps $12.15 as profit after all expenses.
Operating Margin
Core operations generate 8.22 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $2.05 in profit for every $100 of shareholder equity.
ROA
CD Private Equity Fund I generates $2.14 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
CD Private Equity Fund I generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
CD Private Equity Fund I generates weak or negative free cash flow of $-526.79K, restricting financial flexibility.
FCF Per Share
Each share generates $-0.01 in free cash annually.
FCF Yield
CD1.AX converts -3.70% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
19.55
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.20
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.43
vs 25 benchmark
P/S Ratio
Price to sales ratio
236.99
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
16.09
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.02
vs 25 benchmark
ROA
Return on assets percentage
0.02
vs 25 benchmark
ROCE
Return on capital employed
0.01
vs 25 benchmark
How CD1.AX Stacks Against Its Sector Peers
| Metric | CD1.AX Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 19.55 | 18.50 | Neutral |
| ROE | 2.05% | 809.00% | Weak |
| Net Margin | 1214.86% | 2211.00% | Weak |
| Debt/Equity | 0.00 | 0.90 | Strong (Low Leverage) |
| Current Ratio | 16.09 | 691.82 | Strong Liquidity |
| ROA | 2.14% | -24320.00% (disorted) | Weak |
CD1.AX outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews CD Private Equity Fund I's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Value, Dividend, Cyclical
EPS CAGR
N/A
Industry Style: Value, Dividend, Cyclical
FCF CAGR
N/A
Industry Style: Value, Dividend, Cyclical